Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective nonsteroidal estrogen receptor modulators claimed in recent patent

Dec. 11, 2001

AC-7739 possesses cytotoxic and proapoptotic effects in MDR leukemia cell lines

Dec. 11, 2001

Full analysis of phase II data confirm efficacy of BBR-2778 in advanced NHL

Dec. 11, 2001

Apoptotic effects of HA-14-1 characterized in leukemia and lymphoid cells

Dec. 11, 2001

Patients with refractory or relapsed acute leukemia respond to weekly BMS-214662

Dec. 11, 2001

Procyon enters cancer technology option agreement

Dec. 11, 2001

FDA lifts hold on phase III trial of Aptosyn + Taxotere

Dec. 10, 2001

Tubulin polymerization inhibitor effective against refractory tumors in clinical trials

Dec. 10, 2001

PSC-833, an MDR modulator, examined in untreated AML patients of different age groups

Dec. 10, 2001

Sugen presents in vitro data on indolinone related to SU-5416 at Hematology meeting

Dec. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...